AstraZeneca Pharma reports net loss of Rs 33 crore in Q4

14 May 2012 Evaluate

AstraZeneca Pharma India has registered a net loss of Rs 33 crore for the quarter ended March 31, 2012, due to a voluntary recall of sterile products and temporary halt of production at its Bangalore facility. The company had posted a net profit of Rs 8.35 crore for the quarter ended March 31, 2011.

Total income of the company stood at Rs 91.78 crore for the quarter ended March 31, 2012. It was Rs 126.73 crore for the corresponding period previous fiscal, up by 27.58%.

The company said its board of directors has recommended a dividend of Rs 3.50 per equity share of face value of Rs 2 each for the financial year ended March 31, 2012.

AstraZeneca operates through two entities, AstraZeneca Pharma India and AstraZeneca India in the country.

Astrazeneca Pharma I Share Price

9230.50 41.60 (0.45%)
05-Dec-2025 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1521.50
Zydus Lifesciences 933.10
Lupin 2089.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×